EcoDrugPlus

Checkpoint Kinase 2

Ensembl ID : ENSMZEG00005020897
Gene Symbol: CHEK2
3 Cross references
205 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSMZEG00005021319
Gene Symbol: CCKAR
2 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSMZEG00005000406
Gene Symbol: CCKBR
3 Cross references
191 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSMZEG00005001905
Gene Symbol: LOC101466528
3 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSMZEG00005007742
Gene Symbol: LOC106676579
2 Cross references
241 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSMZEG00005007794
Gene Symbol: LOC111500322
2 Cross references
237 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSMZEG00005006502
Gene Symbol: LOC101484290
2 Cross references
236 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSMZEG00005006534
Gene Symbol: LOC101466901
2 Cross references
239 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSMZEG00005002845
Gene Symbol: CETP
3 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSMZEG00005027426
Gene Symbol: CHRM3
3 Cross references
187 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSMZEG00005006024
Gene Symbol: CHRM3
1 Cross references
186 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSMZEG00005003749
Gene Symbol: CHRM5
3 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).